SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,460 | -16.9% | 135 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $18,607 | +6.4% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $17,493 | +16.6% | 135 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $15,000 | +50.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | -9.1% | 135 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $11,000 | -8.3% | 135 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $12,000 | -20.0% | 135 | -18.2% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +200.0% | 165 | +153.8% | 0.00% | +100.0% |
| Q2 2021 | $5,000 | 0.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -54.5% | 65 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $11,000 | +22.2% | 65 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | -10.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +66.7% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -25.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |